Stress, mood, and Parkinson’s disease: selective dysregulation of corticotropin-releasing hormone and urocortin neurocircuits
GeroScience · 10.08.2026
DOI: 10.1007/s11357-026-02475-6 ↗Kurz gefasst
Fachartikel in der Zeitschrift GeroScience, online erschienen am 10.08.2026. Verfasst von Bence Pytel und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anatomy, Medical School, University of Pécs, Szigeti út 12, 7624, Pécs, Hungary. Die Arbeit nennt 97 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Pécsi Tudományegyetem, Innovációs és Technológiai Minisztérium, Nemzeti Kutatási, Fejlesztési és Innovaciós Alap.
Abstract (Originalsprache)
Parkinson’s disease (PD) is an age-associated neurodegenerative disorder in which affective non-motor symptoms substantially contribute to disease burden, yet their neurobiological basis remains incompletely understood. We investigated region-specific alterations of corticotropin-releasing hormone (CRH) family neuropeptides in a rotenone-induced rat model of PD and evaluated the effects of combined dopaminergic (benserazide/L-DOPA) and antidepressant (fluoxetine) treatment. Motor performance, anhedonia-like behavior, dopaminergic neurodegeneration, and CRH-, urocortin 1 (UCN1)-, urocortin 2 (UCN2)-, and urocortin 3 (UCN3)-related molecular changes were assessed using behavioral testing, immunohistochemistry, and RNAscope in situ hybridization. Rotenone treatment induced robust motor impairment, nigral dopaminergic neurodegeneration with α-synuclein-positive Lewy body-like inclusions, and anhedonia-like behavior. Combined dopaminergic–antidepressant therapy improved affective deficits without reversing dopaminergic neuronal loss. Region-specific analyses revealed pronounced dysregulation of hypothalamic and midbrain stress-related neuropeptide systems, including the paraventricular nucleus/CRH, paraventricular nucleus/UCN2, lateral hypothalamic area/UCN3, and centrally projecting Edinger-Westphal nucleus/UCN1, whereas CRH- and UCN3-expressing populations within the extended amygdala remained largely unaffected. Correlation analyses further supported coordinated regulation among hypothalamic CRH-family systems and their association with affective behavioral alterations. These findings identify selective vulnerability of hypothalamic stress-regulatory neuropeptide circuits in experimental PD and suggest that aging-related impairment of stress resilience may contribute to affective non-motor symptoms. Beyond providing a comprehensive neuroanatomical characterization of CRH-family peptide alterations, this work highlights region-specific neuropeptide signaling as a potential framework for developing more precise biomarkers and targeted therapeutic strategies for PD-associated mood disturbances.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Anatomy, Medical School, University of Pécs, Szigeti út 12, 7624, Pécs, Hungary.
- Research Group for Mood Disorders, Centre for Neuroscience, University Medical School, University of Pécs, 7624, Pécs, Hungary.
- Department of Medical Biology, Medical School, University of Pécs, 7624, Pécs, Hungary.
- Department of Pharmacology and Pharmacotherapy, Medical School, University of Pécs, 7624, Pécs, Hungary.
- Department of Anatomy, Medical School, University of Pécs, Szigeti út 12, 7624, Pécs, Hungary. balazs.b.gaszner@aok.pte.hu.
- Research Group for Mood Disorders, Centre for Neuroscience, University Medical School, University of Pécs, 7624, Pécs, Hungary. balazs.b.gaszner@aok.pte.hu.
Förderung
- Pécsi Tudományegyetem
- Innovációs és Technológiai Minisztérium
- Nemzeti Kutatási, Fejlesztési és Innovaciós Alap
- Általános Orvostudományi Kar, Pécsi Tudományegyetem
- National Academy of Scientist Education Program of the National Biomedical Foundation
- University of Pécs
Zitieren
APA
Pytel, B., Márton, Z., Kocsa, J., Berta, G., Kovács, L. Á., Farkas, J., Füredi, N., Havasi, Z., Kormos, V., & Gaszner, B. (2026). Stress, mood, and Parkinson’s disease: selective dysregulation of corticotropin-releasing hormone and urocortin neurocircuits. GeroScience. https://doi.org/10.1007/s11357-026-02475-6
Vancouver
Pytel B, Márton Z, Kocsa J, Berta G, Kovács LÁ, Farkas J, et al. Stress, mood, and Parkinson’s disease: selective dysregulation of corticotropin-releasing hormone and urocortin neurocircuits. GeroScience. 2026. doi:10.1007/s11357-026-02475-6
BibTeX
@article{Pytel2026,
author = {Pytel, Bence and Márton, Zsombor and Kocsa, János and Berta, Gergely and Kovács, László Ákos and Farkas, József and Füredi, Nóra and Havasi, Zsófia and Kormos, Viktória and Gaszner, Balázs},
title = {Stress, mood, and Parkinson’s disease: selective dysregulation of corticotropin-releasing hormone and urocortin neurocircuits},
journal = {GeroScience},
year = {2026},
doi = {10.1007/s11357-026-02475-6}
}
EUVIMED